Robin Tang

Robin Tang is an experienced finance professional specializing in Healthcare Equity Capital Markets Origination, currently serving as an Executive Director at UBS since July 2019. With a focus on financing across equity products, Robin's expertise spans IPOs, Follow-ons, SPACs, PIPEs, and Private Placements within major healthcare subsectors such as Biopharma, HCIT/Services, MedTech, and Diagnostics, while also covering corporate entities, venture capitalists, and institutional investors. Prior roles include Director at SunTrust Robinson Humphrey and Vice President at Nomura, where Robin honed skills in cash equity origination and syndication, particularly with biotech issuers. Educational background includes a BA in Economics from Yale University.